XXII — 22nd Century Share News
0.000.00%
Last trade - 00:00- $0.45m
- -$4.55m
- $17.59m
Brief: 22nd Century Group Reports Q4 Shr Loss $0.12
22nd Century Group Inc expected to post a loss of 6 cents a share - Earnings Preview
Brief: 22nd Century Group Inc Enters Into Securities Purchase Agreement
Brief: 22Nd Century Group (Xxii) Secures $21 Million Debt Financing To Expand Working Capital For Growth Initiatives
22nd Century Group Inc expected to post a loss of 6 cents a share - Earnings Preview
Brief: 22Nd Century Group (Xxii) Acquires Rx Pharmatech Ltd, Greatly Strengthening Uk And EU Market Position
Brief: Gvb Biopharma Announces Fire Occurred At Its GVB Biopharma Distillate & Isolate Manufacturing Facility
Brief: 22nd Century Group's GVB Biopharma Opens New Central Distribution Facility In Netherlands
Brief: 22nd Century Group Reports Q3 Financial Results
22nd Century Group Inc reports results for the quarter ended in September - Earnings Summary
22nd Century Group Inc expected to post a loss of 6 cents a share - Earnings Preview
Brief: 22Nd Century Group To Expand VLN Sales In Three Additional States
Brief: 22nd Century Group Expands VLN® Distributor Network With The Addition Of Specialty Distributor Creager Mercantile
Brief: 22nd Century Group To Initiate Placement For VLN Reduced Nicotine Cigarettes Across Colorado With Eagle Rock Distributing Co
Brief: 22Nd Century Group Inc Says Board Expanded Number Of Directors To Eight
Brief: 22nd Century Group Inc Files For Stock Shelf Of Up To 26 Million Shares Of Common Stock By Selling Stockholders - SEC Filing
22nd Century Group Inc reports results for the quarter ended in June - Earnings Summary
Brief: 22Nd Century Group Reports Q2 Net Loss Per Share Of $0.06
Brief: 22Nd Century Announces $35 Million Registered Direct Offering Priced Above Market Under Nasdaq Rules